

| Revenue | $10 - $100 million See Exact Annual Revenue |
|---|---|
| Employees | 100 - 500Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing |
| Address | 611 Gateway Blvd. Suite 900 South San Francisco, CA 94080 |
| Rigel Pharmaceuticals | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $10 - $100 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Trademark | Date |
|---|---|
| TAVALISSE TOGETHER Medical information services; Providing information services in the field of the treatment of medical disorders for the purpose of patient support, namely, providing medical and healthcare information relating to therapeutic properties of pharmaceuticals and the treatment of diseases and medical conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of diseases and links to such resources; Providing a website featuring medical information, more specifically, a website featuring medical information related to health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and/or drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical care consulting services in the fields of patient treatment and treatment protocols | 10/13/2021 |
| REZLIDHIA Anti-cancer preparations; pharmaceutical products for the prevention and treatment of cancer; biological preparations for the treatment of cancer | 09/04/2019 |
| TAVLISSE Pharmaceutical preparations for the treatment of immune system diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Anti-inflammatory pharmaceutical preparations; Pharmaceutical preparations for the treatment of hematological conditions, diseases and disorders | 04/23/2019 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| EMERALD THERAPEUTICS | South San Francisco, CA | 100 |
| PHARMACYCLICS | Sunnyvale, CA | 59 |
| ALTOS LABS | Redwood City, CA | 39 |
| NURO | Mountain View, CA | 30 |
| SRI INTERNATIONAL | Menlo Park, CA | 27 |
| EXPONENT | Menlo Park, CA | 21 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| PROFESSIONAL RESEARCH CONSULTING | South San Francisco, CA | 100 |
| XIGENT SERVICES | South San Francisco, CA | 0 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |